Evidence map›Paper›PMID 39707377›Full record

ArticleJournal of translational medicine2024

Lactate-related gene signatures as prognostic predictors and comprehensive analysis of immune profiles in nasopharyngeal carcinoma.

Changlin Liu, Chuping Ni, Chao Li, Hu Tian, Weiquan Jian, Yuping Zhong, Yanqing Zhou, Xiaoming Lyu, Yuanbin Zhang, Xiao-Jun Xiang and 2 more

Abstract read
In one paragraph

Article in Journal of translational medicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Article
  13. Review
  14. Review
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Changlin Liu *Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Chuping Ni *Shenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Chao Li *Department of Oncology, The Fifth Affiliated Hospital, Southern Medical University, Guangzhou, Guangdong, 510515, China.
Hu Tian *Department of Urology Surgery, Third Affiliated Hospital, Southern Medical University, Guangzhou, China.
Weiquan JianShenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Yuping ZhongDepartment of Otolaryngology, Shenzhen Longgang Otolaryngology Hospital, Shenzhen, Guangdong, China.
Yanqing ZhouShenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Xiaoming LyuDepartment of Laboratory Medicine, The Third Affiliated Hospital of Southern Medical University, Guangzhou, 510630, China.
Yuanbin ZhangShenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China.
Xiao-Jun XiangDepartment of Healthcare-associated Infection Management, Nanfang Hospital, Southern Medical University, Guangzhou, China. xiangxj151827@163.com.
Chao ChengDepartment of Otolaryngology, Shenzhen Longgang Otolaryngology Hospital, Shenzhen, Guangdong, China. nurswan@126.com.
Xin LiShenzhen Key Laboratory of Viral Oncology, The Clinical Innovation & Research Center (CIRC), Shenzhen Hospital, Southern Medical University, Shenzhen, Guangdong, China. lixin@smu.edu.cn.ORCID 0000-0003-0958-1078

Funding

Shenzhen Key Medical Discipline Construction Fund No.SZXK039Shenzhen Science and technology plan projects. No.JCYJ20230807091701004the Shenzhen Key Laboratory of Viral Oncology No.ZDSYS201707311140430
6 · The paper itself

Abstract

objectivesNasopharyngeal carcinoma (NPC) is an aggressive malignancy with high rates of morbidity and mortality, largely because of its late diagnosis and metastatic potential. Lactate metabolism and protein lactylation are thought to play roles in NPC pathogenesis by modulating the tumor microenvironment and immune evasion. However, research specifically linking lactate-related mechanisms to NPC remains limited. This study aimed to identify lactate-associated biomarkers in NPC and explore their underlying mechanisms, with a particular focus on immune modulation and tumor progression.

methodsTo achieve these objectives, we utilized a bioinformatics approach in which publicly available gene expression datasets related to NPC were analysed. Differential expression analysis revealed differentially expressed genes (DEGs) between NPC and normal tissues. We performed weighted gene coexpression network analysis (WGCNA) to identify module genes significantly associated with NPC. Overlaps among DEGs, key module genes and lactate-related genes (LRGs) were analysed to derive lactate-related differentially expressed genes (LR-DEGs). Machine learning algorithms can be used to predict potential biomarkers, and immune infiltration analysis can be used to examine the relationships between identified biomarkers and immune cell types, particularly M0 macrophages and B cells.

resultsA total of 1,058 DEGs were identified between the NPC and normal tissue groups. From this set, 372 key module genes associated with NPC were isolated. By intersecting the DEGs, key module genes and lactate-related genes (LRGs), 17 lactate-related DEGs (LR-DEGs) were identified. Using three machine learning algorithms, this list was further refined, resulting in three primary lactate-related biomarkers: TPPP3, MUC4 and CLIC6. These biomarkers were significantly enriched in pathways related to "immune cell activation" and the "extracellular matrix environment". Additionally, M0 and B macrophages were found to be closely associated with these biomarkers, suggesting their involvement in shaping the NPC immune microenvironment.

conclusionIn summary, this study identified TPPP3, MUC4 and CLIC6 as lactate-associated clinical modelling indicators linked to NPC, providing a foundation for advancing diagnostic and therapeutic strategies for this malignancy.

Indexed as

Gene Expression Regulation, NeoplasticGene Regulatory NetworksLactic AcidNasopharyngeal CarcinomaNasopharyngeal NeoplasmsBiomarkers, TumorGene Expression ProfilingHumansMachine LearningPrognosisTranscriptomeTumor MicroenvironmentBiomarkers, TumorLactic AcidGEOInfiltrating immunocytesLactylation-related genesMachine learning algorithmsNasopharyngeal carcinoma

Identifiers

PMID39707377
PMCPMC11662464

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.